CPT code 83525 – Total insulin measurement

Key takeaways

CPT code 83525 reports total insulin measured by immunoassay, while free insulin is reported with CPT 83527.

A covered ICD-10-CM diagnosis from the applicable MAC LCD must be on the claim. E11.9, R73.03, R73.09, E28.2, E88.810 and E16.1 are accepted most often.

CO-50 (not medically necessary) is the most common denial, and the fix is matching the submitted diagnosis to the LCD’s covered-diagnosis list.

Pabau, the practice management platform we build, submits US claims through Claim.MD, covering 837P claims, eligibility checks and ERA remittances.

CPT code 83525: Official descriptor and what it measures

CPT code 83525 is the American Medical Association’s (AMA’s) code for measuring total insulin in serum or plasma, with the official descriptor Insulin; total.

Only the AMA creates and maintains the CPT code set, as the AMA’s CPT coding resources state. The code sits in the Pathology and Laboratory section (80047-89398), within the Chemistry subsection (82009-84999). It covers any immunoassay method used to quantify insulin, including radioimmunoassay (RIA), chemiluminescent immunoassay (CLIA), and electrochemiluminescence immunoassay (ECLIA).

“Total” means the assay captures bound and free insulin together, which is the clinically relevant measure for most metabolic workups. The specimen type is serum or plasma; whole blood is not standard for this code.

CPT 83525 vs CPT 83527: Total vs free insulin

CPT code 83525 covers total insulin; CPT code 83527 covers free insulin, the fraction not bound to antibodies or proteins. These are distinct analytes with different clinical applications, and submitting the wrong code for the ordered test is an audit risk.

When both are billed on the same date of service, the record must show that the ordering provider requested each fraction separately. Each one also needs its own clinical rationale. A single note stating “insulin level” without specifying the fraction is insufficient. It can trigger a medical-necessity (CO-50) or records-request denial, or a CO-97 bundling denial if both codes are billed without distinct support.

Clinical indications: When to order CPT code 83525

The most common driver is insulin resistance evaluation, particularly when HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is being calculated. HOMA-IR requires a simultaneous fasting insulin and fasting glucose value, so CPT 83525 and CPT 82947 are ordered together as a pair. Documenting the clinical rationale for the dual order when the tests are ordered prevents billing confusion later.

Laboratory codes in the Chemistry subsection are analyte-specific, so each distinct test ordered takes its own code. The indications below are the clinical scenarios MAC LCDs accept most often.

• Insulin resistance workup: Including HOMA-IR calculation in patients with obesity, hypertriglyceridemia, or acanthosis nigricans
• PCOS evaluation (E28.2): Hyperinsulinemia is a key driver of androgen excess; insulin testing supports the metabolic component of the workup
• Prediabetes screening (R73.03, R73.01): Fasting insulin elevation precedes fasting glucose abnormalities; some ordering providers monitor it as an early marker
• Other abnormal glucose (R73.09): Elevated glucose below diabetes criteria, when neither prediabetes nor impaired fasting glucose is documented
• Type 2 diabetes management (E11.x): Assessing residual beta-cell function or insulin secretory capacity
• Hypoglycemia investigation (E16.0, E16.1): Differentiating endogenous hyperinsulinism from exogenous causes or non-islet-cell tumor hypoglycemia
• Bariatric pre-operative evaluation: Baseline insulin secretion assessment before metabolic surgery
• Metabolic syndrome evaluation (E88.810): Insulin level as part of a broader cardiometabolic risk panel

ICD-10 codes that support medical necessity for CPT 83525

Payers cross-reference the submitted diagnosis code against the covered-diagnosis list in the applicable MAC LCD. If the submitted ICD-10-CM code does not appear on that list, the claim generates a CO-50 denial regardless of clinical justification. The table below reflects the codes most commonly listed across published MAC LCDs for insulin laboratory testing. Code to the highest specificity the CDC/NCHS ICD-10-CM web tool offers. Submitting E11.9 (type 2 diabetes without complications) is acceptable in many LCDs, but some MACs require a complication-specific code. Check the LCD for your jurisdiction before defaulting to the unspecified code.

How to bill CPT code 83525: Step-by-step submission

Accurate submission requires correct place-of-service codes, a clear ordering provider signature, and documentation of the fasting status when the assay requires it. Sound revenue cycle management starts with getting these elements right at the point of order, not at the time of claim scrubbing.

1. Confirm clinical indication: The ordering note must state the clinical reason for the insulin measurement. “Routine labs” is insufficient. Write the specific diagnosis or clinical question being answered (e.g. “insulin resistance evaluation for metabolic syndrome”).
2. Record fasting status: Note in the chart whether the specimen was collected fasting or non-fasting. Some MAC LCDs specify fasting for the test to be covered; others do not. Document it regardless so you can defend the claim if queried.
3. Select the correct place of service: POS 11 (office) for specimens collected in a physician office. POS 81 (independent laboratory) for independent lab billing. POS 22 (outpatient hospital) when applicable.
4. Verify the ICD-10-CM code is on the LCD: Cross-reference the diagnosis against the MAC’s covered-diagnosis list before submission. Use the CMS Clinical Laboratory Fee Schedule files to confirm the code is currently active.
5. Report one unit of service: CPT 83525 is billed as one unit per encounter. Only bill multiple units on the same date if separate specimens from different draws were separately ordered and documented with distinct clinical rationale.
6. Issue an ABN when necessary: Medicare may deny when the diagnosis is not on the LCD. In that case, give the patient a completed Advance Beneficiary Notice (ABN) before the draw.
7. Submit electronically via 837P: Use your claims management software to format the lab claim as an 837P, the electronic CMS-1500. Enter the billing NPI of the performing laboratory or the billing provider.

Medicare reimbursement and LCD requirements

The Centers for Medicare and Medicaid Services (CMS) set the payment amount for CPT 83525 annually through the Clinical Laboratory Fee Schedule (CLFS). The national limitation amount changes each calendar year. A dollar figure written here would soon be outdated. Use the CMS CLFS annual update files for the current rate — CMS publishes the new schedule each November for the following year. Geographic payment adjustments (locality modifiers) apply; the rate in a high-cost metro area differs from a rural MAC jurisdiction.

There is no National Coverage Determination (NCD) for insulin testing. Coverage is therefore governed entirely by MAC-level Local Coverage Determinations (LCDs), so check the patient’s MAC LCD before every 83525 order. On the submission side, Pabau sends US claims through Claim.MD (837P claims, eligibility checks, ERA remittances).

Key coverage principles that most MAC LCDs share:

• Coverage requires a diagnosis from the LCD’s covered-diagnosis list; a clinically reasonable diagnosis alone is not sufficient
• Frequency limitations vary by MAC; some restrict the number of insulin tests covered per year without additional medical necessity documentation
• Screening use alone (without a documented clinical indication) is typically non-covered for Medicare beneficiaries

Local coverage determinations (LCDs) that apply to CPT 83525

Because there is no NCD for insulin testing, each Medicare Administrative Contractor (MAC) may publish its own LCD or billing article. Examples include Novitas (jurisdictions H and L) and CGS (jurisdiction 15). Search the CMS Coverage Database for the one that lists 83525.

Working with a medical claims clearinghouse gives you real-time access to payer-specific edits before submission, reducing the volume of denials that require manual appeal. Here is how to locate the applicable LCD for any given claim:

1. Go to the CMS Coverage Database at coverage.cms.gov
2. Search “insulin” or “clinical laboratory” to filter relevant LCDs
3. Filter by MAC jurisdiction (find the patient’s state in the MAC jurisdiction map)
4. Download the attached article listing covered and non-covered ICD-10-CM codes
5. Cross-reference the patient’s diagnosis before submitting

Common denial reasons and how to fix them

The most preventable denials for CPT 83525 share one root cause: A mismatch between the submitted diagnosis and the LCD’s covered-diagnosis list. Sound denial management workflows treat this check as a pre-submission gate, not a post-denial correction task. Each of the four common denial codes in medical billing for this test maps to one check you can run before submission.

The table below gives the full reason behind each code and the corrective action once the denial has arrived.

Bundling rules: Can CPT 83525 be billed with other codes?

CPT code 83525 and glucose test CPT 82947 are not bundled under the current National Correct Coding Initiative (NCCI) edit tables. Both may be reported on the same date of service when both are ordered and performed. This is the most common pairing for submitting a clean claim for a HOMA-IR calculation: 83525 for total insulin and 82947 for quantitative glucose.

The AAPC CPT-to-ICD-10 crosswalk can confirm medical necessity linkage between the ordered tests and the supporting diagnosis codes before submission. Per CMS’s NCCI edits page, NCCI edits are updated quarterly. Check the current quarter’s edit table before relying on an older non-bundle relationship.

• 83525 + 82947 (glucose quantitative): Permitted together; document that both were ordered for HOMA-IR or concurrent metabolic assessment
• 83525 + 83527 (free insulin): Permitted together when both fractions were separately ordered; each requires its own documented clinical rationale in the chart
• 83525 + 84681 (C-peptide): Generally permitted together when separating endogenous from exogenous insulin is clinically indicated. No NCCI bundle conflict exists, but payer LCDs may apply frequency restrictions
• 83525 within a panel: If the insulin test is part of a custom panel billed under a panel code, check the panel descriptor. When it already includes insulin, billing 83525 as well duplicates the charge

Documentation requirements for audit defense

An audit of CPT 83525 claims focuses on five elements. Missing any one of them can be enough for a Recovery Audit Contractor (RAC) to demand repayment, even when the test was clinically appropriate. Build this into your pre-visit and post-visit documentation workflows.

The five-element audit checklist for CPT 83525:

1. Clinical indication in the note: The ordering note must state the specific clinical reason for the insulin test. Use the same, or equivalent, language as the ICD-10 code submitted. “Insulin resistance evaluation” paired with E88.819 passes this check; “labs ordered” does not.
2. Ordering provider signature: A dated, authenticated signature by a licensed ordering provider must appear in the chart. Electronic signatures are acceptable if the system meets authentication standards.
3. Fasting status documented: Record whether the draw was fasting or non-fasting. If the MAC LCD specifies fasting, an undocumented non-fasting draw is undefendable on appeal.
4. Diagnosis supports LCD criteria: The ICD-10-CM code submitted must appear on the MAC LCD’s covered-diagnosis list. Attach a copy of the relevant LCD page to the encounter documentation.
5. Retention period observed: Retention periods vary by payer and state. Check your MAC’s and your state’s rules, and keep records for the longest period that applies.

CPT 83525 for specific patient populations

Several patient populations generate insulin orders regularly, and each carries a nuance that affects coverage.

PCOS patients: E28.2 is widely accepted across MAC LCDs for insulin testing. Still, confirm that the LCD in your jurisdiction lists it before assuming coverage. PCOS workups often also include androgen testing and lipid panels. Document the insulin order as its own clinical question rather than folding it into a vague “PCOS labs” note.

Bariatric surgery candidates: Pre-operative metabolic panels for bariatric patients frequently include CPT 83525. E66.01 (morbid obesity) alone is often not accepted for insulin testing. Pair it with the metabolic indication (E88.810, E88.819 or E11.x), and check the LCD. Some LCDs treat obesity alone as a non-covered indication for insulin testing.

Pediatric patients: Some MAC LCDs apply age restrictions to insulin testing coverage. Verify whether the applicable LCD includes pediatric-specific coverage criteria, particularly for insulin resistance workups in adolescents with PCOS or early metabolic syndrome.

How Pabau keeps CPT 83525 orders and claims on one record

A lab order for 83525 often passes through three systems. The clinician orders in the EHR, the lab portal holds the result, and the biller rekeys the claim. Each handoff is a chance for the diagnosis on the order to drift from the diagnosis on the claim.

In Pabau, practices can switch on US lab ordering. Quest tests are ordered from the patient record with the practice’s own Quest login, and Labcorp orders are placed in Labcorp Link. Results from both sync back to the record automatically, next to the ordering note.

Billing runs from the same record. Pabau submits US claims through Claim.MD, with 837P claims, eligibility checks and ERA remittances. Your team still checks the diagnosis against the LCD, but it works from one chart, so a CO-50 is quicker to trace and correct.

Keep lab orders and lab claims together

Order Quest tests from the patient record, see Quest and Labcorp results sync back, and submit 837P claims through Claim.MD. Your team traces a CO-50 to its source in one chart.

Book a demo

Conclusion

CPT code 83525 denials are almost always preventable. The diagnosis code either matches the LCD or it does not, and catching that mismatch before submission costs nothing. Catching it after a CO-50 denial costs time, staff, and sometimes the payment entirely if the appeal window closes.

So move the LCD check to the moment of ordering. Record the covered diagnosis, the fasting status and any ABN at the draw. The claim then goes out with the evidence a MAC asks for on review. Pabau keeps the lab order, the result and the 837P claim on one patient record. Book a demo to see a lab claim travel from order to remittance in one place.

Continue your research

Comparing clearinghouse costs for lab claims? Claim.MD pricing and plan overview explains what the clearinghouse charges and how its plans differ.

Want to understand how electronic remittance works after a claim pays or denies? Understanding electronic remittance advice (ERA) covers 835 transaction reading, ERA posting, and CARC denial code interpretation.

Building a denial prevention workflow from scratch? What is medical billing gives a full revenue cycle walkthrough from charge capture through payment posting, including where lab codes most often derail.

Frequently asked questions